Clik here to view.
MC10, Inc. Partners with Marubun Corporation to add Japanese Distribution...
LEXINGTON, Mass. & TOKYO MC10, Inc., the healthcare technology company specializing in stretchable body worn computing systems, and Marubun Corporation, the leading Japanese distributor of...
View ArticleClik here to view.
PeptiDream Announces Research Collaboration with BIND Therapeutics
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a research collaboration with US-based BIND Therapeutics...
View ArticleClik here to view.
Clinical Trial Involving Regenerative Cell Treatment for Patients with...
MOUNTAIN VIEW, Calif. & TOKYO SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders and the United States subsidiary of SanBio Co., Ltd., announced today that...
View ArticleClik here to view.
Sosei Subsidiary Heptares and Allergan Announce Global R&D and...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces that its wholly-owned subsidiary, Heptares Therapeutics has entered into a definitive agreement with Allergan...
View ArticleClik here to view.
22nd Century宣布极低尼古丁MAGIC香烟和极致尼古丁RED SUN香烟在澳大利亚上市
纽约州克拉伦斯 (美国商业资讯) — 烟草减害领域的领先者、植物生物技术公司22nd Century Group, Inc. (NYSE MKT: XXII)今天宣布收到澳大利亚烟草经销商Quay Tobacco Trading PTY, LTD的首笔订货单。该订单包括极低尼古丁MAGIC品牌香烟和“极致尼古丁”RED SUN香烟，这是22nd Century产品首次批量销往亚太地区。...
View ArticleClik here to view.
CANbridge Submits Investigational New Drug Application to Taiwan Food and...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has completed the Investigational New Drug (IND)...
View ArticleClik here to view.
Abpro宣布与Essex Bio合作投资开发抗体治疗药物
马萨诸塞州沃本 (美国商业资讯)– 处于合成生物学前沿的综合性生命科学公司Abpro今天宣布与总部在中国的生物制药公司Essex Bio缔结伙伴关系。Abpro将发挥Abpro的DiversImmune™平台的优势，与Essex合作开发免疫肿瘤科和眼科领域的多个单克隆抗体。作为该协议的一部分，Abpro从Essex Bio获得350万美元的股权投资，从其分公司获得数额未披露的资金。 Smart...
View ArticleClik here to view.
22ndセンチュリーが超低ニコチン紙巻きたばこ「マジック」と究極のニコチン紙巻きたばこ「レッドサン」のオーストラリアでの発売を発表
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減でリードする植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE MKT: XXII）は本日、オーストラリアのタバコ販売会社Quay Tobacco Trading PTY, LTDから初注文を受けたと発表しました。注文には超低ニコチン紙巻きたばこブランド「マジック」と、「究極のニコチン」（Extreme...
View ArticleClik here to view.
Clik here to view.
Prana Regains Compliance with NASDAQ Continued Listing RequirementsContinues...
MELBOURNE, Australia Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced that it has received a notice dated April 8th 2016 from the Listing Qualifications Department of NASDAQ Stock...
View ArticleClik here to view.
Protochips推进液体原位电子显微镜
北卡罗莱纳州莫里斯维尔 –(美国商业资讯)–Protochips宣布推出Poseidon Select 液体原位系统。这款Poseidon增强版使科学家和工程师能够在各类环境下对材料和生物学样本进行成像，该系统采用单一固定器，配有用于加热和电化学的选件。无论是研究电化学还是仅对静态、流动或已加热液体中的样本进行简单成像，Poseidon...
View ArticleClik here to view.
プロトチップス、液体用In Situ電子顕微鏡で前進
米ノースカロライナ州モリスビル （ビジネスワイヤ）–プロトチップスは、液体用in situシステムであるポセイドン・セレクト（Poseidon...
View ArticleClik here to view.
Chi-Med Initiates First-in-Human Clinical Trial of Novel PI3K Inhibitor HMPL-689
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated the first-in-human (“FIH”)...
View ArticleClik here to view.
Hutchison China MediTech Limited Announces Exercise of Overallotment Option
LONDON Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that the underwriters of its offering of American depositary shares (“ADSs”) on the Nasdaq Global Select Market (the...
View ArticleClik here to view.
Cytori Strengthens Global Patent Portfolio
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today a number of key additions to its patent portfolio in Japan and Europe. The company now has 85 global patents issued, 12 of which...
View ArticleClik here to view.
Materialise and Canon Lifecare Solutions Sign Distribution Agreement
LEUVEN, Belgium Materialise NV (NASDAQ:MTLS), is proud to announce the signing of an agreement that will see Canon Lifecare Solutions distributing software solutions from the Materialise Mimics...
View ArticleClik here to view.
22nd Century强调颠覆性专利吸烟减害产品
纽约州克拉伦斯 (美国商业资讯) — 植物生物技术公司22nd Century Group, Inc. (NYSE MKT: XXII)是烟草减害领域的领先者。该公司今天向股东发布了下列信函，该信函收录在该公司面向股东的2015年报中： 尊敬的股东伙伴们： 2015年是我公司转型之年，而2016年22nd Century将更上一层楼。...
View ArticleClik here to view.
Acucela Announces End of Treatment Period in Phase 2b/3 Clinical Trial of...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
ZEMBRACE™ SymTouch™ (Sumatriptan Injection) 3 mg, Approved by the FDA in...
HYDERABAD, India & PRINCETON, N.J. Promius Pharma LLC, a subsidiary of Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today that ZEMBRACE SymTouch is now commercially...
View ArticleClik here to view.
美国临床肿瘤学会支持WIN 2016研讨会：以创新途径改善癌症患者治疗效果
法国维勒瑞夫 –(美国商业资讯)–WIN联合会(WIN)自豪地宣布，其致力于“以创新途径改善癌症患者治疗效果”研讨会已获得美国临床肿瘤学会(ASCO®)的支持，列为该学会的优秀科学项目。WIN主席、MD安德森个体化癌症疗法研究所所长John Mendelsohn说：“这是ASCO®连续第8年支持这一独特的科学论坛，该论坛已成为精准癌症医学领域的重要活动。” WIN...
View Article